Alpha1-adrenoceptor-mediated breakdown of phosphatidylinositol 4,5-bisphosphate inhibits pinacidil-activated ATP-sensitive K+ currents in rat ventricular myocytes

Circ Res. 2002 Aug 9;91(3):232-9. doi: 10.1161/01.res.0000029971.60214.49.

Abstract

Phosphatidylinositol 4,5-bisphosphate (PIP2) stimulates ATP-sensitive K+ (K(ATP)) channel activity. Because phospholipase C (PLC) hydrolyzes membrane-bound PIP2, which in turn may potentially decrease K(ATP) channel activity, we investigated the effects of the alpha1-adrenoceptor-G(q)-PLC signal transduction axis on pinacidil-activated K(ATP) channel activity in adult rat and neonatal mouse ventricular myocytes. The alpha1-adrenoceptor agonist methoxamine (MTX) reversibly inhibited the pinacidil-activated K(ATP) current in a concentration-dependent manner (IC50 20.9+/-6.6 micromol/L). This inhibition did not occur when the specific alpha1-adrenoceptor antagonist, prazosin, was present. An involvement of G proteins is suggested by the ability of GDPbetaS to prevent this response. Blockade of PLC by U-73122 (2 micromol/L) or neomycin (2 mmol/L) attenuated the MTX-induced inhibition of K(ATP) channel activity. In contrast, the MTX response was unaffected by protein kinase C inhibition or stimulation by H-7 (100 micro mol/L) or phorbol 12,13-didecanoate. The MTX-induced inhibition became irreversible in the presence of wortmannin (20 micro mol/L), an inhibitor of phosphatidylinositol-4 kinase, which is expected to prevent membrane PIP2 replenishment. In excised inside-out patch membranes, pinacidil induced a significantly rightward shift of ATP sensitivity of the channel. This phenomenon was reversed by pretreatment of myocytes with MTX. Direct visualization of PIP2 subcellular distribution using a PLCdelta pleckstrin homology domain-green fluorescent protein fusion constructs revealed reversible translocation of green fluorescent protein fluorescence from the membrane to the cytosol after alpha1-adrenoceptor stimulation. Our data demonstrate that alpha1-adrenoceptor stimulation reduces the membrane PIP2 level, which in turn inhibits pinacidil-activated K(ATP) channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / pharmacology*
  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Agonists / pharmacology
  • Androstadienes / pharmacology
  • Animals
  • Animals, Newborn
  • Cell Membrane / metabolism
  • Cells, Cultured
  • Electric Conductivity
  • Enzyme Inhibitors / pharmacology
  • GTP-Binding Proteins / physiology
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • Methoxamine / pharmacology
  • Mice
  • Phosphatidylinositol 4,5-Diphosphate / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Pinacidil / antagonists & inhibitors*
  • Potassium Channels / physiology*
  • Protein Kinase C / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha-1 / physiology*
  • Type C Phospholipases / physiology
  • Ventricular Function*
  • Wortmannin

Substances

  • Adrenergic alpha-1 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Androstadienes
  • Enzyme Inhibitors
  • Phosphatidylinositol 4,5-Diphosphate
  • Phosphoinositide-3 Kinase Inhibitors
  • Potassium Channels
  • Receptors, Adrenergic, alpha-1
  • Pinacidil
  • Adenosine Triphosphate
  • Protein Kinase C
  • Type C Phospholipases
  • GTP-Binding Proteins
  • Methoxamine
  • Wortmannin